• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[101例川崎病巨大冠状动脉瘤患儿的中长期随访]

[Middle and long-term follow-up of 101 children with giant coronary artery aneurysm of Kawasaki disease].

作者信息

Xiong Y, Zhang Y L, Du Z D

机构信息

Department of Cardiology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.

出版信息

Zhonghua Er Ke Za Zhi. 2021 Feb 2;59(2):101-106. doi: 10.3760/cma.j.cn112140-20201124-01052.

DOI:10.3760/cma.j.cn112140-20201124-01052
PMID:33548955
Abstract

To summarize the clinical features, middle-and long-term prognosis of Kawasaki disease (KD) with giant coronary artery aneurysm (GCAA). In this retrospective cohort study, a cross-sectional analysis was conducted on 101 KD children with GCAA in the KD with GCAA database established by Beijing Children's Hospital, Capital Medical University in 2004. GCAA was diagnosed as coronary artery absolute lumen diameter ≥8.0 mm. All patients were followed up regularly. The endpoint was the time of last follow-up or the death time. test or χ test was used for comparison between groups. A total of 101 KD children with GCAA were enrolled, including 82 males (81.2%) and 19 females (18.8%). The age of disease onset was 2.5 (1.0, 4.5) years. The follow-up duration was 4.5 (2.7, 7.5) years, with a longest of 19 years. All children received routine treatment with aspirin and warfarin, and clopidogrel was added in severe cases. At the end of follow-up, 13 cases (12.9%) had cardiac enlargement, 11 cases (10.9%) developed heart failure, 13 cases (12.9%) experienced myocardial infarction, 2 cases (2.0%) underwent coronary artery bypass graft and 6 cases (5.9%) died. A total of 170 coronary arteries were involved, including 24 (14.1%) GCAAs on the main trunk of left coronary artery, 10 (5.9%) GCAAs on left circumflex, 57 (33.5%) GCAAs on left anterior descending, 78 (45.9%) GCAAs on the middle segments of right coronary artery, and 1 (0.6%) GCAA in the distal segments of right coronary artery. Eleven cases (10.9%) recovered with the coronary artery absolute lumen diameter of all GCAAs below 4.0 mm. Among 170 branches with GCAAs, 28 (16.5%) regressed below 4.0 mm. No significant difference was found in the regression rates between right and left GCAA (18.7% (17/91) 13.9% (11/79), χ²=2.473, 0.116). There was no statistically significant difference in retraction between unilateral GCAA and bilateral GCAA (16.1% (9/56) 4.4% (2/45), χ=2.381, 0.123). GCAA of KD occurred more common in the middle segments of right and left anterior descending coronary arteries. The incidence of adverse cardiac events and the mortality rate in children with GCAA complicated with KD was high. Their long-term prognosis was poor.

摘要

总结川崎病(KD)合并巨大冠状动脉瘤(GCAA)的临床特征、中长期预后。在这项回顾性队列研究中,对首都医科大学附属北京儿童医院2004年建立的KD合并GCAA数据库中101例KD合并GCAA患儿进行横断面分析。GCAA诊断为冠状动脉绝对管腔直径≥8.0mm。所有患者均定期随访。终点为末次随访时间或死亡时间。组间比较采用检验或χ检验。共纳入101例KD合并GCAA患儿,其中男性82例(81.2%),女性19例(18.8%)。发病年龄为2.5(1.0,4.5)岁。随访时间为4.5(2.7,7.5)年,最长19年。所有患儿均接受阿司匹林和华法林常规治疗,重症病例加用氯吡格雷。随访结束时,13例(12.9%)出现心脏扩大,11例(10.9%)发生心力衰竭,13例(12.9%)发生心肌梗死,2例(2.0%)接受冠状动脉搭桥术,6例(5.9%)死亡。共累及170支冠状动脉,其中左冠状动脉主干24支(14.1%)、左旋支10支(5.9%)、左前降支57支(33.5%)、右冠状动脉中段78支(45.9%)、右冠状动脉远端1支(0.6%)。11例(10.9%)患儿冠状动脉绝对管腔直径均恢复至4.0mm以下。在170支合并GCAA的分支中,28支(16.5%)回缩至4.0mm以下。左右侧GCAA回缩率差异无统计学意义(18.7%(17/91)对13.9%(11/79),χ²=2.473,P=0.116)。单侧GCAA与双侧GCAA回缩情况差异无统计学意义(16.1%(9/56)对4.4%(2/45),χ=2.381,P=0.123)。KD合并的GCAA多见于左右冠状动脉前降支中段。KD合并GCAA患儿不良心脏事件发生率及死亡率高,长期预后差。

相似文献

1
[Middle and long-term follow-up of 101 children with giant coronary artery aneurysm of Kawasaki disease].[101例川崎病巨大冠状动脉瘤患儿的中长期随访]
Zhonghua Er Ke Za Zhi. 2021 Feb 2;59(2):101-106. doi: 10.3760/cma.j.cn112140-20201124-01052.
2
[Follow up and review of patients with Kawasaki disease complicated with giant coronary artery aneurysms for a decade: a single-institution experience].川崎病合并巨大冠状动脉瘤患者十年随访与复查:单机构经验
Zhonghua Er Ke Za Zhi. 2015 Jan;53(1):40-4.
3
Incidence and timing of coronary thrombosis in Kawasaki disease patients with giant coronary artery aneurysm.川崎病巨大冠状动脉瘤患者冠状动脉血栓形成的发生率和时间。
Thromb Res. 2023 Jan;221:30-34. doi: 10.1016/j.thromres.2022.11.014. Epub 2022 Nov 23.
4
A practical nomogram for predicting coronary thrombosis for Kawasaki disease patients with medium or large coronary artery aneurysm.用于预测伴有中等或大型冠状动脉瘤的川崎病患者冠状动脉血栓形成的实用列线图。
Clin Exp Med. 2023 Aug;23(4):1317-1324. doi: 10.1007/s10238-022-00893-2. Epub 2022 Sep 23.
5
Intravascular ultrasound of coronary arteries in children. Assessment of the wall morphology and the lumen after Kawasaki disease.儿童冠状动脉血管内超声检查。川崎病后血管壁形态及管腔评估。
Circulation. 1994 Jan;89(1):258-65. doi: 10.1161/01.cir.89.1.258.
6
Recurrent events of acute coronary syndrome in young adult patients after Kawasaki disease.川崎病后年轻成年患者急性冠状动脉综合征的复发事件
Cardiol Young. 2024 Apr;34(4):809-814. doi: 10.1017/S1047951123003499. Epub 2023 Oct 18.
7
[Evaluation of treatment and management of Kawasaki coronary artery disease based on clinical severity classification].基于临床严重程度分类的川崎病冠状动脉疾病治疗与管理评估
Zhonghua Er Ke Za Zhi. 2015 Sep;53(9):690-5.
8
Giant coronary aneurysms exceeding 5 cm in size.直径超过5厘米的巨大冠状动脉瘤。
Interact Cardiovasc Thorac Surg. 2012 Jul;15(1):33-6. doi: 10.1093/icvts/ivs111. Epub 2012 Apr 14.
9
Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease. A multicenter cooperative study.川崎病冠状动脉疾病患者心肌血运重建的长期预后。一项多中心合作研究。
J Thorac Cardiovasc Surg. 1994 Mar;107(3):663-73; discussion 673-4.
10
Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.川崎病可能出现面神经麻痹,表明冠状动脉病变。
Clin Rheumatol. 2021 Oct;40(10):4191-4197. doi: 10.1007/s10067-021-05791-8. Epub 2021 May 31.

引用本文的文献

1
Shaanxi Provincial Diagnosis and Treatment Center of Kawasaki Disease.陕西省川崎病诊疗中心。
Zhongguo Dang Dai Er Ke Za Zhi. 2021;23(9):867-876. doi: 10.7499/j.issn.1008-8830.2107110.